AstraZeneca (OTCMKTS:AZNCF) Shares Down 1.6%

AstraZeneca PLC (OTCMKTS:AZNCF)’s share price traded down 1.6% on Friday . The stock traded as low as $155.14 and last traded at $155.14. 849 shares were traded during mid-day trading, a decline of 70% from the average session volume of 2,860 shares. The stock had previously closed at $157.73.

AstraZeneca Stock Down 1.6 %

The stock has a 50 day simple moving average of $162.79 and a 200-day simple moving average of $152.23.

AstraZeneca Cuts Dividend

The firm also recently announced a dividend, which was paid on Monday, September 9th. Investors of record on Friday, August 9th were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Wednesday, August 7th. AstraZeneca’s dividend payout ratio is currently 343.14%.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in AstraZeneca stock. Kennedy Capital Management LLC acquired a new stake in shares of AstraZeneca PLC (OTCMKTS:AZNCF) during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 37,554 shares of the company’s stock, valued at approximately $5,068,000. 40.87% of the stock is owned by institutional investors and hedge funds.

About AstraZeneca

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.